SAKAR HEALTHCARE
Quarterly Results Analysis [Dec2024]
SAKAR HEALTHCARE Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹43 Cr | ₹43 Cr | ₹41 Cr | ₹43 Cr | ₹37 Cr | ₹34 Cr | ₹39 Cr | ₹41 Cr |
Expenses | ₹32 Cr | ₹31 Cr | ₹30 Cr | ₹32 Cr | ₹28 Cr | ₹25 Cr | ₹30 Cr | ₹33 Cr |
Operating Income | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
Interest | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Depreciation | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr |
Profit Before Tax | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit After Tax | ₹5 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr |
EPS | ₹2.07 | ₹2.21 | ₹1.11 | ₹1.43 | ₹0.95 | ₹1.70 | ₹1.49 | ₹2.06 |
Industry Peers & Returns | 1W | 1M | 1Y |
SAKAR HEALTHCARE | 7.7% | -4.8% | -26.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2.8% | -7.5% | 2.3% |
DIVIS LABORATORIES | -0.2% | -9.9% | 60.4% |
CIPLA | 4.4% | -0.6% | -1% |
TORRENT PHARMACEUTICALS | 4.8% | -2.9% | 15.4% |
DR REDDYS LABORATORIES | NA | -9.4% | -10.2% |
MANKIND PHARMA | -0.7% | -8.8% | 7.1% |
ZYDUS LIFESCIENCES | 2.5% | -11.4% | -5.5% |
LUPIN | 2.9% | -8.1% | 20.9% |
SAKAR HEALTHCARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 1.49 % |
Y-o-Y | 16.63 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹43 Cr | 1.49 | |
Sep2024 | ₹43 Cr | 3.96 | |
Jun2024 | ₹41 Cr | -4.44 | |
Mar2024 | ₹43 Cr | 15.67 | |
Dec2023 | ₹37 Cr | 9.23 | |
Sep2023 | ₹34 Cr | -12.59 | |
Jun2023 | ₹39 Cr | -4.09 | |
Mar2023 | ₹41 Cr | - |
SAKAR HEALTHCARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 2.23 % |
Y-o-Y | 30.50 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹12 Cr | 2.23 | |
Sep2024 | ₹12 Cr | 7.50 | |
Jun2024 | ₹11 Cr | -2.46 | |
Mar2024 | ₹11 Cr | 21.74 | |
Dec2023 | ₹9 Cr | -3.74 | |
Sep2023 | ₹9 Cr | 3.69 | |
Jun2023 | ₹9 Cr | 15.98 | |
Mar2023 | ₹8 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 0.71 % |
Y-o-Y | 11.90 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 27.08% | 0.71 | |
Sep2024 | 26.89% | 3.42 | |
Jun2024 | 26% | 2.08 | |
Mar2024 | 25.47% | 5.25 | |
Dec2023 | 24.2% | -11.90 | |
Sep2023 | 27.47% | 18.66 | |
Jun2023 | 23.15% | 20.89 | |
Mar2023 | 19.15% | - |
SAKAR HEALTHCARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -5.50 % |
Y-o-Y | 118.51 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹5 Cr | -5.50 | |
Sep2024 | ₹5 Cr | 98.84 | |
Jun2024 | ₹2 Cr | -22.72 | |
Mar2024 | ₹3 Cr | 50.48 | |
Dec2023 | ₹2 Cr | -42.94 | |
Sep2023 | ₹4 Cr | 27.90 | |
Jun2023 | ₹3 Cr | -27.54 | |
Mar2023 | ₹4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -6.87 % |
Y-o-Y | 87.43 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 10.44 % | -6.87 | |
Sep2024 | 11.21 % | 91.30 | |
Jun2024 | 5.86 % | -19.17 | |
Mar2024 | 7.25 % | 30.16 | |
Dec2023 | 5.57 % | -47.80 | |
Sep2023 | 10.67 % | 46.36 | |
Jun2023 | 7.29 % | -24.46 | |
Mar2023 | 9.65 % | - |
SAKAR HEALTHCARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -6.33 % |
Y-o-Y | 117.89 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹2.07 | -6.33 | |
Sep2024 | ₹2.21 | 99.10 | |
Jun2024 | ₹1.11 | -22.38 | |
Mar2024 | ₹1.43 | 50.53 | |
Dec2023 | ₹0.95 | -44.12 | |
Sep2023 | ₹1.7 | 14.09 | |
Jun2023 | ₹1.49 | -27.67 | |
Mar2023 | ₹2.06 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD